24/03/2026
Tuberculosis remains a major global health challenge, and addressing all forms of TB—including Latent Tuberculosis Infection (LTBI)—is an important part of ongoing public health efforts.
Individuals with LTBI do not show symptoms, yet monitoring and appropriate evaluation play a role in supporting TB control strategies.
At Boditech Med, we provide diagnostic solutions designed to support TB screening in various clinical settings.
Our portfolio includes ichroma™ IGRA-TB and AFIAS IGRA-TB, based on Interferon-Gamma Release Assay (IGRA) technology, which may support the assessment of immune response associated with TB infection.
This World TB Day, we stand together in supporting global efforts to raise awareness and strengthen TB control initiatives.